Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Daza Arnedo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Case Reports in Nephrology|May 22, 2024
The Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA), Associated with Renal Compromise and Cutaneous Calcinosis: A Case Report and Literature ReviewCristian Betancur Henao, Juan Guillermo Rifaldo, Rafael Vicente-Pérez, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Mechanisms of Diabetic Kidney DiseaseJorge Rico-Fontalvo, Gustavo Aroca, Jose Cabrales, et al.
Archivos De Cardiologia De Mexico|July 1, 2026
[The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine]Rodrigo Daza-Arnedo, Carlos M Restrepo, Diego Araiza-Garaygordobil, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|April 27, 2026
Metabolic Kidney Disease: A New Concept in the Interaction Between Obesity, Prediabetes, Diabetes and Liver DysfunctionJorge Rico Fontalvo, Rodrigo Daza Arnedo, María Raad Sarabia, et al.
Jornal Brasileiro De Nefrologia|November 8, 2024
Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspectiveJorge Rico-Fontalvo, Maricely Reina, María José Soler, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 18, 2026
Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping ReviewJorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Alicia Elbert, et al.
Biomolecules|May 16, 2023
Novel Biomarkers of Diabetic Kidney DiseaseJorge Rico-Fontalvo, Gustavo Aroca-Martínez, Rodrigo Daza-Arnedo, et al.
Nefrologia|November 15, 2024
Prediabetes and CKD: Does a causal relationship existJorge Rico Fontalvo, María José Soler, Rodrigo Daza Arnedo, et al.
International Journal of Nephrology|March 10, 2023
Critically Ill Patients with Renal Hyperfiltration: Optimizing Antibiotic DoseJorge Rico-Fontalvo, José Correa-Guerrero, María Cristina Martínez-Ávila, et al.
Kidney Medicine|December 23, 2021
Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative ReviewRodrigo Daza-Arnedo, Jorge-Eduardo Rico-Fontalvo, Nehomar Pájaro-Galvis, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Case Reports in Nephrology|May 22, 2024
The Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA), Associated with Renal Compromise and Cutaneous Calcinosis: A Case Report and Literature ReviewCristian Betancur Henao, Juan Guillermo Rifaldo, Rafael Vicente-Pérez, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Mechanisms of Diabetic Kidney DiseaseJorge Rico-Fontalvo, Gustavo Aroca, Jose Cabrales, et al.
Archivos De Cardiologia De Mexico|July 1, 2026
[The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine]Rodrigo Daza-Arnedo, Carlos M Restrepo, Diego Araiza-Garaygordobil, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|April 27, 2026
Metabolic Kidney Disease: A New Concept in the Interaction Between Obesity, Prediabetes, Diabetes and Liver DysfunctionJorge Rico Fontalvo, Rodrigo Daza Arnedo, María Raad Sarabia, et al.
Jornal Brasileiro De Nefrologia|November 8, 2024
Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspectiveJorge Rico-Fontalvo, Maricely Reina, María José Soler, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 18, 2026
Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping ReviewJorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Alicia Elbert, et al.
Biomolecules|May 16, 2023
Novel Biomarkers of Diabetic Kidney DiseaseJorge Rico-Fontalvo, Gustavo Aroca-Martínez, Rodrigo Daza-Arnedo, et al.
Nefrologia|November 15, 2024
Prediabetes and CKD: Does a causal relationship existJorge Rico Fontalvo, María José Soler, Rodrigo Daza Arnedo, et al.
International Journal of Nephrology|March 10, 2023
Critically Ill Patients with Renal Hyperfiltration: Optimizing Antibiotic DoseJorge Rico-Fontalvo, José Correa-Guerrero, María Cristina Martínez-Ávila, et al.
Kidney Medicine|December 23, 2021
Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative ReviewRodrigo Daza-Arnedo, Jorge-Eduardo Rico-Fontalvo, Nehomar Pájaro-Galvis, et al.
Pageof 2